Stock PHAR PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Pharming Group N.V. Nasdaq

Equities

PHAR

US71716E1055

Delayed Nasdaq
Other stock markets
 11:01:12 2024-06-06 am EDT 		5-day change 1st Jan Change
8.68 USD +13.02% Intraday chart for Pharming Group N.V. -2.80% -24.06%
May. 31 Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug MT
May. 30 Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. PHAR Stock
  5. Revisions Pharming Group N.V.